Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT04615923

HEALEY ALS Platform Trial - Regimen D Pridopidine

Sponsor: Merit E. Cudkowicz, MD

Conditions Amyotrophic Lateral Sclerosis

Interventions Matching Placebo Pridopidine

Updated 10 times since 2020 Last updated: Aug 12, 2023 Started: Dec 18, 2020 Primary completion: Jul 14, 2022 Completion: Jul 14, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Amyotrophic Lateral Sclerosis and is currently completed. Merit E. Cudkowicz, MD leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Feb 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Feb 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Sep 2023 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

Status: Active Not Recruiting → Completed
Jun 2023 — Sep 2023 [monthly]

Active Not Recruiting PHASE2_PHASE3

▶ Show 5 earlier versions

Sep 2022 — Jun 2023 [monthly]

Active Not Recruiting PHASE2_PHASE3
May 2022 — Sep 2022 [monthly]

Active Not Recruiting PHASE2_PHASE3
Feb 2022 — May 2022 [monthly]

Active Not Recruiting PHASE2_PHASE3

Status: Enrolling By Invitation → Active Not Recruiting
Jan 2021 — Feb 2022 [monthly]

Enrolling By Invitation PHASE2_PHASE3

Status: Not Yet Recruiting → Enrolling By Invitation
Dec 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Merit E. Cudkowicz, MD
Prilenia

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States